Clinical Trials in Ohio

Showing 3481-3500 of 20,938 trials

Effects of Tobacco Cut and Nicotine Form on the Abuse Liability of Moist Snuff

NCT06249984

This clinical trial tests the effects of tobacco cut and nicotine form on the abuse liability in participants who use moist snuff (smokeless tobacco \[SLT\]). Two features of moist snuff that are key targets of manipulation from the tobacco industry and drivers of its addiction potential are length of tobacco cut (long versus fine) and nicotine form (low versus high levels of nicotine in the free-base form). Finer tobacco cuts and higher levels of free-base nicotine (FBN) result in faster, greater nicotine delivery. Researchers want to gain information on how certain characteristics of moist snuff affect how long people use it, how it delivers nicotine, or how much people like it. This clinical trial may provide justifications for local, state, or federal regulations aimed at reducing the appeal and addictiveness of moist snuff.

Tobacco-Related Carcinoma

Ohio State University Comprehensive Cancer Center80 participantsStarted Dec 2024

Columbus, Ohio, United States • Columbus, Ohio, United States

COMPLETEDNA32 miles

Perceptions of Vaping Products

NCT06868368

This clinical trial studies the effects, appeal, and abuse liability of 6-methyl nicotine (metatine) electronic cigarettes among young adults.

Abuse TobaccoExposure

Ohio State University Comprehensive Cancer Center53 participantsStarted Mar 2025

Columbus, Ohio, United States

Effects of Tobacco Cut and Nicotine Form on the Abuse Liability of Moist Snuff

Perceptions of Vaping Products

Find Trials by Condition in Ohio

Distal Ischemic Stroke Treatment With Adjustable Low-profile Stentriever

Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury

Spreading Depolarizations in Traumatic Brain Injury

ExCrossV Multi Site Trial for Vascularized High Risk Keratoplasty

Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

Diagnosing Clinically Significant Prostate Cancer In African American and White Men With Elevated PSA

Study of SX-682 Plus Enzalutamide in Men With ARPI-Resistant Metastatic Castration Resistant Prostate Cancer

Advanced XLIF Monitoring Multicenter Study

Dupilumab in Allergic Fungal Rhinosinusitis (AFRS) (LIBERTY-AFRS-AI)

Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout

Phase I/II Study of [225Ac]Ac-PSMA-R2 in PSMA-positive Prostate Cancer, With/Without Prior 177Lu-PSMA RLT

A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment

NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems)

A Study of U3-1402 (Patritumab Deruxtecan) in Subjects With Metastatic Breast Cancer

Phagenyx® Registry Study

BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma

Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)